Surgery Partners (SGRY) Depreciation & Amortization (CF) (2014 - 2026)

Surgery Partners has reported Depreciation & Amortization (CF) for 13 years, with the latest figure at $38.5 million in Q1 2026.

• Quarterly Depreciation & Amortization (CF) rose 6.06% year-over-year to $38.5 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $178.2 million (up 14.82% YoY) and the FY2025 annual result came in at $176.0 million, up 15.33% from the prior year.
• Depreciation & Amortization (CF) fell to $38.5 million in Q1 2026 per SGRY's latest filing, from $59.9 million in the prior quarter.
• Over five years, Depreciation & Amortization (CF) peaked at $59.9 million in Q4 2025 and troughed at $24.4 million in Q2 2023.
• A 5-year average of $35.3 million and a median of $33.7 million in 2023 frame the typical range for Depreciation & Amortization (CF).
• The widest YoY moves for Depreciation & Amortization (CF): up 76.7% in 2025, down 21.31% in 2025.
• Over 5 years, Depreciation & Amortization (CF) stood at $29.6 million in 2022, then advanced by 5.07% to $31.1 million in 2023, then gained by 9.0% to $33.9 million in 2024, then surged by 76.7% to $59.9 million in 2025, then sank by 35.73% to $38.5 million in 2026.
• According to Business Quant data, Depreciation & Amortization (CF) over the past three periods registered $38.5 million, $59.9 million, and $39.5 million for Q1 2026, Q4 2025, and Q3 2025 respectively.